Director, Center for Outcomes Research, Real World Evidence and Epidemiology

At Genmab, we are dedicated to building extraordinary futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals' unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees. Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so. Does this inspire you and feel like a fit? Then we would love to have you join us The Role This position will be responsible for developing and executing HTA strategy in partnership with Market Access. This role requires strong scientific leadership, knowledge of HTA processes, cross‑functional influence, and external engagement experience with HTA processes/ Agencies. As part of a growing group, this role will also be in a unique position to deliver locally and contribute to global strategy while helping shape the build of the function in Europe as the company grows. This position can be filled in the UK, France, Germany, Italy, Spain, Netherlands or Denmark. Responsibilities Drives the development, execution, and implementation of the European evidence needs for HTA & post‑approval RWE for Genmab products across European markets of interest in alignment with market access and medical affairs. Co‑develops the JCA submission and HTA dossier with the Market Access and Pricing Lead to ensure the evidence on clinical and economic value of Genmab products is represented in a scientifically robust manner, consistent with evolving HTA standards. Provides input into global HEOR and RWE deliverables (e.g., economic model, global value dossier, global value evidence framework, ITC methods) re: local country needs and leads validation of regional/local input. Leads evidence generation activities relevant to local markets including localization of global deliverables and post‑approval evidence generation activities. Develop customer‑facing materials (e.g., field decks) to communicate value to access decision makers, champions the review through the MRL process and supports training of customer facing teams as appropriate. Serves as a scientific HEOR/ RWE SME to market access in pricing and HTA negotiations. As a member of the CORE team, contribute to department strategy and objectives as well as represent CORE on key initiatives. As a member of the CORE team, support pipeline assets as needed. Requirements Graduate (PhD or Masters) degree and relevant work experience in health economics, outcomes research, epidemiology, health services research, public health, health policy Minimum of 7 years in the pharmaceutical industry or consulting in the direct conduct of health economics, outcomes research, real world evidence and epidemiology studies Oncology experience preferred Strong commercial and clinical strategic mindset. Demonstrated research accomplishments as evidenced by a history of peer‑reviewed publications. Excellent knowledge of market access environment and HTA process in key European markets. Significant Experience participating in HTA processes at country level in Germany, France or UK. Ability to work well in a team and cross‑functional environment, as well as work independently with limited supervision. Ability to travel. This position can be filled in the UK, France, Germany, Italy or Spain. Ability to work successfully under pressure in a fast‑paced environment and with tight timelines. Ability to be proactive, enthusiastic and goal orientated. Strong communication skills - both oral and written. About You You are genuinely passionate about our purpose You bring precision and excellence to all that you do You believe in our rooted‑in‑science approach to problem‑solving You are a generous collaborator who can work in teams with a broad spectrum of backgrounds You take pride in enabling the best work of others on the team You can grapple with the unknown and be innovative You have experience working in a fast‑growing, dynamic company (or a strong desire to) You work hard and are not afraid to have a little fun while you do so Locations Genmab maximizes the efficiency of an agile working environment, when possible, for the betterment of employee work‑life balance. Our offices are crafted as open, community‑based spaces that work to connect employees while being immersed in our powerful laboratories. Whether you’re in one of our office spaces or working remotely, we thrive on connecting with each other to innovate. About Genmab Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard‑working, innovative and collaborative team has invented next‑generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T‑cell engagers, antibody‑drug conjugates, next‑generation immune checkpoint modulators and effector function‑enhanced antibodies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock‑Your‑Socks‑Off (KYSO®) antibody medicines. Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X. Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com). Please note that if you are applying for a position in the Netherlands, Genmab’s policy for all permanently budgeted hires in NL is initially to offer a fixed‑term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the fixed‑term employment contract. #J-18808-Ljbffr